Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression

GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression

  • Post published:September 29, 2023
  • Post category:Press Release
Read more about the article GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates

GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates

  • Post published:August 23, 2023
  • Post category:Press Release
Read more about the article GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights

GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights

  • Post published:May 11, 2023
  • Post category:Press Release
Read more about the article GH Research Reports Full Year 2022 Financial Results and Provides Business Updates

GH Research Reports Full Year 2022 Financial Results and Provides Business Updates

  • Post published:March 2, 2023
  • Post category:Press Release
Read more about the article GH Research Provides Business Updates and Highlights Key Upcoming Milestones

GH Research Provides Business Updates and Highlights Key Upcoming Milestones

  • Post published:January 25, 2023
  • Post category:Press Release
Read more about the article GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates

GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates

  • Post published:January 7, 2023
  • Post category:Press Release
Read more about the article GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates

GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates

  • Post published:August 23, 2022
  • Post category:Press Release
Read more about the article GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

  • Post published:May 18, 2022
  • Post category:Press Release
Read more about the article GH Research Announces Closing of $125 Million Oversubscribed Series B Financing

GH Research Announces Closing of $125 Million Oversubscribed Series B Financing

  • Post published:April 12, 2021
  • Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More